Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Pyoderma Gangrenosum
- Spesolimab in Pyoderma Gangrenosum
- Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
- Deucravacitinib in PG
- Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum
- Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
- Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
- Exploratory Study of IFX-1 in Subjects With Pyoderma Gangrenosum
- A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
- Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum
- Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
- An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
- A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
- An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
- Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum
- Canakinumab for Pyoderma Gangrenosum
- Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
- Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
- Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum